Sonnet Biotherapeutics Holdings Stock Annual Yield

SONN Stock  USD 1.55  0.01  0.65%   
Sonnet Biotherapeutics Holdings fundamentals help investors to digest information that contributes to Sonnet Biotherapeutics' financial success or failures. It also enables traders to predict the movement of Sonnet Stock. The fundamental analysis module provides a way to measure Sonnet Biotherapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sonnet Biotherapeutics stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Sonnet Biotherapeutics Holdings Company Annual Yield Analysis

Sonnet Biotherapeutics' Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.

Yield

 = 

Income from Security

Current Share Price

More About Annual Yield | All Equity Analysis

Sonnet Annual Yield Driver Correlations

Understanding the fundamental principles of building solid financial models for Sonnet Biotherapeutics is extremely important. It helps to project a fair market value of Sonnet Stock properly, considering its historical fundamentals such as Annual Yield. Since Sonnet Biotherapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Sonnet Biotherapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Sonnet Biotherapeutics' interrelated accounts and indicators.
0.830.040.280.460.250.890.180.68-0.330.050.530.20.38-0.2-0.270.040.18-0.070.180.160.130.180.16
0.83-0.15-0.160.410.280.490.510.39-0.340.170.240.040.43-0.16-0.21-0.110.210.080.090.490.150.540.49
0.04-0.150.15-0.26-0.040.22-0.060.280.39-0.260.330.330.39-0.32-0.330.59-0.28-0.42-0.210.08-0.31-0.060.07
0.28-0.160.150.01-0.290.59-0.880.63-0.020.130.12-0.1-0.33-0.03-0.1-0.1-0.190.040.57-0.850.38-0.86-0.85
0.460.41-0.260.010.280.340.150.04-0.160.010.34-0.03-0.10.110.07-0.120.16-0.020.140.010.140.10.02
0.250.28-0.04-0.290.280.210.490.15-0.05-0.520.60.580.53-0.58-0.530.60.25-0.55-0.410.37-0.520.30.37
0.890.490.220.590.340.21-0.150.81-0.25-0.10.630.330.3-0.25-0.320.210.12-0.220.18-0.150.05-0.18-0.15
0.180.51-0.06-0.880.150.49-0.15-0.25-0.15-0.240.170.340.62-0.11-0.080.260.34-0.23-0.540.97-0.440.960.97
0.680.390.280.630.040.150.81-0.25-0.19-0.030.30.210.31-0.31-0.380.2-0.06-0.260.21-0.20.05-0.26-0.2
-0.33-0.340.39-0.02-0.16-0.05-0.25-0.15-0.190.280.12-0.18-0.14-0.26-0.30.28-0.86-0.15-0.15-0.110.23-0.05-0.1
0.050.17-0.260.130.01-0.52-0.1-0.24-0.030.28-0.46-0.77-0.590.250.29-0.63-0.510.540.27-0.210.77-0.01-0.19
0.530.240.330.120.340.60.630.170.30.12-0.460.630.5-0.55-0.560.620.04-0.5-0.250.14-0.320.060.13
0.20.040.33-0.1-0.030.580.330.340.21-0.18-0.770.630.78-0.55-0.530.830.46-0.69-0.470.33-0.650.180.32
0.380.430.39-0.33-0.10.530.30.620.31-0.14-0.590.50.78-0.58-0.60.660.27-0.46-0.470.67-0.570.520.66
-0.2-0.16-0.32-0.030.11-0.58-0.25-0.11-0.31-0.260.25-0.55-0.55-0.580.95-0.580.20.260.51-0.090.24-0.04-0.09
-0.27-0.21-0.33-0.10.07-0.53-0.32-0.08-0.38-0.30.29-0.56-0.53-0.60.95-0.560.260.240.4-0.060.17-0.01-0.05
0.04-0.110.59-0.1-0.120.60.210.260.20.28-0.630.620.830.66-0.58-0.560.06-0.88-0.440.28-0.610.130.27
0.180.21-0.28-0.190.160.250.120.34-0.06-0.86-0.510.040.460.270.20.260.06-0.180.020.26-0.390.20.26
-0.070.08-0.420.04-0.02-0.55-0.22-0.23-0.26-0.150.54-0.5-0.69-0.460.260.24-0.88-0.180.17-0.230.5-0.12-0.23
0.180.09-0.210.570.14-0.410.18-0.540.21-0.150.27-0.25-0.47-0.470.510.4-0.440.020.17-0.530.57-0.49-0.53
0.160.490.08-0.850.010.37-0.150.97-0.2-0.11-0.210.140.330.67-0.09-0.060.280.26-0.23-0.53-0.470.951.0
0.130.15-0.310.380.14-0.520.05-0.440.050.230.77-0.32-0.65-0.570.240.17-0.61-0.390.50.57-0.47-0.23-0.45
0.180.54-0.06-0.860.10.3-0.180.96-0.26-0.05-0.010.060.180.52-0.04-0.010.130.2-0.12-0.490.95-0.230.96
0.160.490.07-0.850.020.37-0.150.97-0.2-0.1-0.190.130.320.66-0.09-0.050.270.26-0.23-0.531.0-0.450.96
Click cells to compare fundamentals
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
Competition

In accordance with the recently published financial statements, Sonnet Biotherapeutics Holdings has an Annual Yield of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Sonnet Biotherapeutics Current Valuation Drivers

We derive many important indicators used in calculating different scores of Sonnet Biotherapeutics from analyzing Sonnet Biotherapeutics' financial statements. These drivers represent accounts that assess Sonnet Biotherapeutics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Sonnet Biotherapeutics' important valuation drivers and their relationship over time.
202020212022202320242025 (projected)
Market Cap387.0M118.9M51.0M23.8M4.4M68.9M
Enterprise Value380.0M91.4M48.2M21.7M4.4M78.2M

Sonnet Fundamentals

About Sonnet Biotherapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Sonnet Biotherapeutics Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sonnet Biotherapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sonnet Biotherapeutics Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
When determining whether Sonnet Biotherapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sonnet Biotherapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sonnet Biotherapeutics Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sonnet Biotherapeutics Holdings Stock:
Check out Sonnet Biotherapeutics Piotroski F Score and Sonnet Biotherapeutics Altman Z Score analysis.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sonnet Biotherapeutics. If investors know Sonnet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sonnet Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(10.45)
Revenue Per Share
0.959
Quarterly Revenue Growth
52.688
Return On Assets
(1.34)
Return On Equity
(2.85)
The market value of Sonnet Biotherapeutics is measured differently than its book value, which is the value of Sonnet that is recorded on the company's balance sheet. Investors also form their own opinion of Sonnet Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sonnet Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sonnet Biotherapeutics' market value can be influenced by many factors that don't directly affect Sonnet Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sonnet Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sonnet Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sonnet Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.